Cargando…

Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer

Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Chia-Cheng, Huang, Shu-Pin, Lee, Yung-Chin, Huang, Chao-Yuan, Liu, Chia-Chu, Hour, Tzyh-Chyuan, Huang, Chun-Nung, You, Bang-Jau, Chang, Ta-Yuan, Huang, Chun-Hsiung, Bao, Bo-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554749/ https://www.ncbi.nlm.nih.gov/pubmed/23359804 http://dx.doi.org/10.1371/journal.pone.0054627

Ejemplares similares

Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
por: Huang, Shu-Pin, et al.
Publicado: (2012)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
por: Huang, Ling-Chun, et al.
Publicado: (2022)

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy
por: Geng, Jiun-Hung, et al.
Publicado: (2016)

Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer’s Disease Patients and Patients’ Adult Children
por: Huo, Chieh, et al.
Publicado: (2022)

NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
por: Huang, Shu-Pin, et al.
Publicado: (2021)

IL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis
por: Suen, Jau‐Ling, et al.
Publicado: (2019)

The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males
por: Cheng, Kai-Hung, et al.
Publicado: (2013)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
por: Hou, Wei-Hsien, et al.
Publicado: (2017)

Impact of Interleukin-10 Gene Polymorphisms on Survival in Patients with Colorectal Cancer
por: Ting, Wen-Chien, et al.
Publicado: (2013)

Lower SHBG level is associated with higher leptin and lower adiponectin levels as well as metabolic syndrome, independent of testosterone
por: Liu, Chia-Chu, et al.
Publicado: (2017)

Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020)

Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference
por: Fu, Yu-Ke, et al.
Publicado: (2022)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
por: Lai, Chih-Jen, et al.
Publicado: (2019)

The Associations of Novel Vitamin D(3) Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males
por: Cheng, Kai-Hung, et al.
Publicado: (2015)

Salvage Radiotherapy Plus Androgen Deprivation Therapy for High-Risk Prostate Cancer with Biochemical Failure after High-Intensity Focused Ultrasound as Primary Treatment
por: Huang, Ying-Che, et al.
Publicado: (2022)

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
por: Liu, Jui-Ming, et al.
Publicado: (2021)

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma
por: Pu, Yeong-Shiau, et al.
Publicado: (2009)

Clinical predictor of survival following docetaxel-based chemotherapy
por: LEE, HSIANG-YING, et al.
Publicado: (2014)

Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
por: Liao, Kuang-Ming, et al.
Publicado: (2019)

Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study
por: Yang, Teng-Kai, et al.
Publicado: (2020)

Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
por: Lin, Victor C., et al.
Publicado: (2016)

The Promotion of Migration and Myogenic Differentiation in Skeletal Muscle Cells by Quercetin and Underlying Mechanisms
por: Hour, Tzyh-Chyuan, et al.
Publicado: (2022)

Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan
por: Huang, Wen-Kuan, et al.
Publicado: (2020)

Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2015)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study
por: Lin, Hsin-Le, et al.
Publicado: (2022)

Androgen Deprivation Therapy and Cardiovascular Risk in Chinese Patients with Nonmetastatic Carcinoma of Prostate
por: Huang, Gang, et al.
Publicado: (2014)

Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
por: Lu, Yu-Cheng, et al.
Publicado: (2022)

Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor
por: Wang, Bi-Juan, et al.
Publicado: (2022)

Androgen deprivation modulates the inflammatory response induced by irradiation
por: Wu, Chun-Te, et al.
Publicado: (2009)

Long-Term Prescription of α-Blockers Decrease the Risk of Recurrent Urolithiasis Needed for Surgical Intervention-A Nationwide Population-Based Study
por: Liu, Chia-Chu, et al.
Publicado: (2015)

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma
por: Lee, Chi-Ho, et al.
Publicado: (2017)

Purified Astaxanthin from Haematococcus pluvialis Promotes Tissue Regeneration by Reducing Oxidative Stress and the Secretion of Collagen In Vitro and In Vivo
por: Chou, Hsin-Yu, et al.
Publicado: (2020)

The use of androgen deprivation therapy for prostate cancer and its effect on the subsequent dry eye disease: a population-based cohort study
por: Chien, Hsiang-Wen, et al.
Publicado: (2022)

Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reports
por: Wei, Wei, et al.
Publicado: (2021)

Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications
por: Pu, Yeong-Shiau, et al.
Publicado: (2012)

AB084. Sexual anxiety correlate to visual attention bias in sex situation: an eye-tracking study
por: Huang, Yung-Jui, et al.
Publicado: (2017)

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Phthalate exposure and reproductive hormones and sex-hormone binding globulin before puberty – Phthalate contaminated-foodstuff episode in Taiwan
por: Wen, Hui-Ju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r6qted0aec0u5ql4k6088c6pi0